Coronavirus News Roundup, March 20 – March 26
Pandemic highlights for the week -- Read more on ScientificAmerican.com
Pandemic highlights for the week -- Read more on ScientificAmerican.com
Today we bring you the third episode in a new podcast series: COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya... -- Read more on ScientificAmerican.com
Phone calls may be integral to connecting with people who are lonely and isolated -- Read more on ScientificAmerican.com
A now familiar 21st-century scenario of circumventing public-health strictures played out as well at the beginning of the 20th century -- Read more on ScientificAmerican.com
Undercounting or ignoring cases of the disease on the continent could lead to new variants that might derail efforts to end the pandemic -- Read more on ScientificAmerican.com
SARS-CoV-2 may be settling into a limited set of mutations -- Read more on ScientificAmerican.com
The catch-all term plays into a cultural notion that estrogen is what makes a woman a woman -- Read more on ScientificAmerican.com
Differences in life expectancy, car ownership and language may contribute to the racial and ethnic disparities -- Read more on ScientificAmerican.com
It can be well-intentioned, but it’s a dangerous path that leaves little room for a real understanding of gender and gender identity -- Read more on ScientificAmerican.com
Human behavior and social inequity are huge confounding factors -- Read more on ScientificAmerican.com
Pandemic highlights for the week -- Read more on ScientificAmerican.com
The New York Times columnist discusses police brutality, racial disparities of the pandemic and diversifying the workplace -- Read more on ScientificAmerican.com
The 19th-century nurse and public health researcher understood the importance of light in fighting and preventing disease -- Read more on ScientificAmerican.com
Willingness is rising, even among skeptical groups, at a time when there are still not enough doses to go around -- Read more on ScientificAmerican.com
A likely culprit is hormone-disrupting chemicals -- Read more on ScientificAmerican.com
Uptake by patients and physicians has been low in the U.S., even though some therapies have been authorized for months -- Read more on ScientificAmerican.com